Shares of Global Blood were jumping over 10% this week on news that the company has secured FDA approval for a new pill to treat sickle cell disease. Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. It was … Continue reading “Global Blood Lands FDA Approval for Pill to Treat Sickle Cell Disease”
Tag: fda approval
Biotech & Pharma
The FDA Has Approved Spark Therapeutics’ Luxturna Therapy
In what is the first in the field of gene therapy, Spark Therapeutics' Luxturna has…
December 19, 2017
Biotech & Pharma
Gilead Shares Move Higher After FDA Approves its Cancer Drug
Gilead made an excellent move acquiring Kite Pharma because a drug that Kite developed has…
October 19, 2017